Intellia Therapeutics Announces U.S. FDA Acceptance of Investigational New Drug Application for NTLA-5001, its CRISPR/Cas9-Engineered TCR-T Cell Candidate for Acute Myeloid Leukemia
September 16, 2021 07:30 ET
|
Intellia Therapeutics, Inc.
NTLA-5001 is Intellia’s first ex vivo candidate using its proprietary cell engineering process for the treatment of cancer to enter clinical studyNTLA-5001 targets Wilms’ Tumor 1 (WT1), an...
CRISPR Based Therapeutics Market, 2030
September 09, 2021 08:43 ET
|
Research and Markets
Dublin, Sept. 09, 2021 (GLOBE NEWSWIRE) -- The "CRISPR Based Therapeutics Market by Type of Therapy, Therapeutic Approach, Therapeutic Area, and Key Geographical Regions: Industry Trends and Global...
The Worldwide High Content Screening/Imaging Industry Should Reach $2.3 Billion by 2026
September 03, 2021 06:13 ET
|
Research and Markets
Dublin, Sept. 03, 2021 (GLOBE NEWSWIRE) -- The "High Content Screening/Imaging: Technologies and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global...
Asia-Pacific $6.93 Bn Gene Therapy Market to 2030
August 26, 2021 08:43 ET
|
Research and Markets
Dublin, Aug. 26, 2021 (GLOBE NEWSWIRE) -- The "Asia-Pacific Gene Therapy Market Research Report: Type, Vector Type, Application, End User - Industry Analysis and Demand Forecast to 2030" report has...
Global $5.57 Billion Cell Therapy Technologies Markets, 2015-2019, 2023F, 2025F, 2030F: Cell Processing; Cell Preservation, Distribution, and Handling; Process Monitoring and Quality Control
August 11, 2021 05:18 ET
|
Research and Markets
Dublin, Aug. 11, 2021 (GLOBE NEWSWIRE) -- The "Cell Therapy Technologies Global Market Report 2021: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.The global...
United Soybean Board Awards $1 Million to Amfora to Continue Development of High-Protein Soy
August 09, 2021 08:10 ET
|
Amfora Inc
SAN FRANCISCO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- The United Soybean Board awarded $1 million to Amfora, Inc., a biotechnology company that is applying gene editing to sustainably feed the planet, to...
Global Oligonucleotide Synthesis Market Report 2021: Market is Poised for Explosive Growth as Gene Technology Moves into Mainstream Healthcare, Food Production and, Even, Data Storage
August 03, 2021 06:58 ET
|
Research and Markets
Dublin, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides and including Customized...
Global Prime Editing and CRISPR Market is Expected to Reach $23.49 Billion by 2030: Says AMR
July 13, 2021 08:54 ET
|
Allied Market Research
Portland, OR, July 13, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Prime Editing And CRISPR Market was estimated at $2.69 billion in 2020 and is...
Global $34.31 Billion Cell and Gene Therapy Markets, 2015-2020, 2025F, 2030F
July 12, 2021 04:38 ET
|
Research and Markets
Dublin, July 12, 2021 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy market Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change" report has been added to...
Global Cell Therapy Market Report 2021 Featuring Fibrocell Science., JCR Pharma, PHARMICELL, Osiris, MEDIPOST, Vericel, Anterogen, Kolon TissueGene, Stemedica Cell Technologies, and AlloCure
June 30, 2021 04:33 ET
|
Research and Markets
Dublin, June 30, 2021 (GLOBE NEWSWIRE) -- The "Cell Therapy Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The global cell...